On Tuesday, Shares of General Electric Company (NYSE:GE), lost -0.62% to $27.92. The stock attained the volume of 43.20 million shares.
GE (GE) declared that Brackett Denniston, GE’s general counsel and senior vice president, will retire from the Company at the end of 2015. Alex Dimitrief, currently senior vice president and general counsel for GE Capital, will assume the role of GE general counsel and senior vice president, effective November 1, and Brackett will focus on the Alstom transition and Appliances transaction through the end of the year.
Brackett has spent 19 years of distinguished service at GE, joining the company as vice president and senior counsel of litigation and legal policy in 1996. He was named general counsel in 2004 and senior vice president in 2005. In addition to his general counsel and senior vice president role, his recent GE leadership positions include: director of GE Capital Corporation and the GE Foundation; member of the Corporate Executive Council; and Chairman of the Policy Compliance Review Board.
After graduating from Harvard Law School, Brackett began his career as a law clerk for Judge Herbert Y. C. Choy of the United States Court of Appeals for the Ninth Circuit. He then worked as an associate and partner at Goodwin Procter LLP in Boston, where he specialized in complex civil litigation, securities matters and white collar crime cases. He served as chief of the major frauds unit for the U.S. Attorney’s Office in Massachusetts, where he was responsible for white-collar-crime prosecutions. Preceding to joining GE, he served as chief legal counsel to Governor William F. Weld of Massachusetts.
General Electric Company operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment.
At the end of Tuesday’s trade, Shares of Johnson & Johnson (NYSE:JNJ), declined -0.51% to $95.50.
Johnson & Johnson (JNJ) declared sales of $17.1 billion for the third quarter of 2015, a decrease of 7.4% as contrast to the third quarter of 2014. Operational sales results raised 0.8% and the negative impact of currency was 8.2%. Domestic sales reduced 0.6%. International sales reduced 13.7%, reflecting operational growth of 2.1% and a negative currency impact of 15.8%. Not Taking Into Account the net impact of acquisitions, divestitures and hepatitis C sales, on an operational basis, worldwide sales raised 5.6%, domestic sales raised 7.7% and international sales raised 3.8%. The Company also declared its Board of Directors has approved the repurchase of up to $10 billion of the company’s common stock.
Net earnings and diluted earnings per share for the third quarter of 2015 were $3.4 billion and $1.20, respectively. Third quarter 2015 net earnings comprised of after-tax intangible amortization expense of about $0.4 billion and a charge for after-tax special items of about $0.4 billion. Third quarter 2014 net earnings comprised of after-tax intangible amortization expense of about $0.3 billion and a net gain for after-tax special items of about $0.4 billion.
Not Taking Into Account after-tax intangible amortization expense and special items, adjusted net earnings for the current quarter were $4.2 billion and adjusted diluted earnings per share were $1.49, representing decreases of 9.4% and 7.5%, respectively, as contrast to the same period in 2014. On an operational basis, adjusted diluted earnings per share raised 1.2%.
The Company raised its adjusted earnings guidance for full-year 2015 to $6.15 - $6.20 per share. The Company’s guidance excludes the impact of after-tax intangible amortization expense and special items.
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Finally, Shares of IAMGOLD Corp (USA) (NYSE:IAG), ended its last trade with 1.09% gain, and closed at $1.86.
The stock closed at a distance of 8.93% from 20-day simple moving average. In the last trading session, the stock’s price moved -10.42% below its 200 day moving average, changing hands as low as $1.83 per share. The stock is presently trading 12.16% above its SMA 50.
IAMGOLD Corporation will release its third quarter 2015 financial results after market hours on Tuesday, November 3rd, 2015.
CONFERENCE CALL
A conference call will be held on Wednesday, November 4th 2015, at 8:30 a.m. (Eastern Standard Time) for a talk about with administration regarding the Company’s operating performance and financial results for the third quarter of 2015. A webcast of the conference call will be accessible through the Company’s website – www.iamgold.com.
IAMGOLD Corporation primarily engages in the exploration, development, and operation of gold mining properties. It also explores for silver and copper deposits.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
